Your browser doesn't support javascript.
loading
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®.
Speich, Benjamin; Chammartin, Frédérique; Smith, Daniel; Stoeckle, Marcel P; Amico, Patrizia; Eichenberger, Anna L; Hasse, Barbara; Schuurmans, Macé M; Müller, Thomas; Tamm, Michael; Dickenmann, Michael; Abela, Irene A; Trkola, Alexandra; Hirsch, Hans H; Manuel, Oriol; Cavassini, Matthias; Hemkens, Lars G; Briel, Matthias; Mueller, Nicolas J; Rauch, Andri; Günthard, Huldrych F; Koller, Michael T; Bucher, Heiner C; Kusejko, Katharina.
Afiliación
  • Speich B; Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel, Basel, Switzerland. benjamin.speich@usb.ch.
  • Chammartin F; Nuffield Department of Orthopaedics, Centre for Statistics in Medicine, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. benjamin.speich@usb.ch.
  • Smith D; Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Stoeckle MP; University of Zurich, Institute of Medical Virology, Zurich, Switzerland.
  • Amico P; Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, University of Basel, Basel, Switzerland.
  • Eichenberger AL; Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
  • Hasse B; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
  • Schuurmans MM; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Müller T; Division of Pulmonology, University Hospital Zurich, Zurich, Switzerland.
  • Tamm M; Nephrology Clinic, University Hospital Zurich, Zurich, Switzerland.
  • Dickenmann M; Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital of Basel, Petersgraben 4, 4031, Basel, Switzerland.
  • Abela IA; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
  • Trkola A; University of Zurich, Institute of Medical Virology, Zurich, Switzerland.
  • Hirsch HH; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Manuel O; University of Zurich, Institute of Medical Virology, Zurich, Switzerland.
  • Cavassini M; Clinical Virology, Laboratory Medicine, University Hospital Basel, Basel, Switzerland.
  • Hemkens LG; Transplantation & Clinical Virology, Department Biomedicine, University Hospital Basel, Basel, Switzerland.
  • Briel M; Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Mueller NJ; Transplantation Center, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Rauch A; Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Günthard HF; Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Koller MT; Meta-Research Innovation Center Berlin (METRICS-B), Berlin Institute of Health, Berlin, Germany.
  • Bucher HC; Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA.
  • Kusejko K; Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel, Basel, Switzerland.
Trials ; 22(1): 724, 2021 Oct 21.
Article en En | MEDLINE | ID: mdl-34674742

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies Límite: Aged / Humans Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies Límite: Aged / Humans Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: Suiza